Overview
Silent cerebral infarction (SCI) refers to small, asymptomatic areas of brain damage detected incidentally on imaging, often associated with increased risk for future neurological events such as stroke, cognitive decline, and dementia 24.Diagnosis
Imaging: Detected primarily via MRI or CT scans showing focal areas of hypodensity without clinical symptoms 24.
Risk Factors Assessment: Evaluate for hypertension, low BMI, abnormal ECG, carotid artery plaques, and decreased serum bilirubin levels 234.
Cognitive Screening: Use tools like Montreal Cognitive Assessment (MoCA) for detecting cognitive impairment associated with SCI 3.Management
Lifestyle Modifications: Focus on blood pressure control, weight management, and cardiovascular risk reduction 4.
Risk Factor Management: Address hypertension and low BMI, especially in elderly patients 4.
Monitoring: Regular follow-up with cognitive assessments and neuroimaging to monitor progression 3.Special Populations
Elderly: Hypertension and low BMI are significant risk factors 4.
Comorbidities: Abnormal ECG and carotid artery plaques independently increase risk 3.Key Recommendations
Screen for Serum Bilirubin Levels: Lower bilirubin levels correlate with higher prevalence of SCI; consider bilirubin as a novel biochemical indicator for SCI risk assessment (Evidence: Moderate) 2.
Manage Hypertension and BMI: In elderly patients, particularly those aged 65-75 years and those ≥81 years, controlling hypertension and maintaining adequate BMI can reduce SCI risk (Evidence: Moderate) 4.
Utilize MoCA for Cognitive Assessment: Employ MoCA over MMSE for more sensitive detection of cognitive deficits in patients with SCI (Evidence: Moderate) 3.References
1 Choi KT, Kwak SG, Chang MC. Does injury of the thalamocortical connection between the mediodorsal nucleus of the thalamus and the dorsolateral prefrontal cortex affect motor recovery after cerebral infarct?. Acta neurologica Belgica 2021. link
2 Li RY, Cao ZG, Zhang JR, Li Y, Wang RT. Decreased serum bilirubin is associated with silent cerebral infarction. Arteriosclerosis, thrombosis, and vascular biology 2014. link
3 Zhao J, Tang H, Sun J, Wang B, Chen S, Fu Y. Analysis of cognitive dysfunction with silent cerebral infarction: a prospective study in Chinese patients. Metabolic brain disease 2012. link
4 Kotani K, Osaki Y, Sakane N, Adachi S, Ishimaru Y. Risk factors for silent cerebral infarction in the elderly. Archives of medical research 2004. link
5 Martinsson L, Yang X, Beck O, Wahlgren NG, Eksborg S. Pharmacokinetics of dexamphetamine in acute stroke. Clinical neuropharmacology 2003. link
6 Chen HH, Chien CH, Liu HM. Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 1994. link